https://www.marketscreener.com/quote/stock/HUTCHMED-CHINA-LIMITED-59660104/news/HUTCHMED-Announces-that-it-has-Completed-Enrollment-of-a-Phase-II-III-Trial-of-Fruquintinib-in-Combi-45554672/?utm_source=telegram&utm_medium=social&utm_campaign=share